BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3253289)

  • 1. Foetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells.
    Schor SL; Schor AM; Grey AM; Rushton G
    J Cell Sci; 1988 Jul; 90 ( Pt 3)():391-9. PubMed ID: 3253289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblasts from cancer patients display a mixture of both foetal and adult-like phenotypic characteristics.
    Schor SL; Schor AM; Rushton G
    J Cell Sci; 1988 Jul; 90 ( Pt 3)():401-7. PubMed ID: 3253290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer.
    Schor SL; Schor AM
    J Cell Sci Suppl; 1987; 8():165-80. PubMed ID: 3332659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between adult and foetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity.
    Chen WY; Grant ME; Schor AM; Schor SL
    J Cell Sci; 1989 Nov; 94 ( Pt 3)():577-84. PubMed ID: 2632585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the migration stimulating factor produced by fetal and cancer patient fibroblasts: effect on hyaluronic and synthesis.
    Schor SL; Schor AM; Grey AM; Chen J; Rushton G; Grant ME; Ellis I
    In Vitro Cell Dev Biol; 1989 Aug; 25(8):737-46. PubMed ID: 2768134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effects of TGF-beta 1 and MSF on fibroblast migration and hyaluronic acid synthesis. Possible implications for dermal wound healing.
    Ellis I; Grey AM; Schor AM; Schor SL
    J Cell Sci; 1992 Jul; 102 ( Pt 3)():447-56. PubMed ID: 1506427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration stimulating factor (MSF): its structure, mode of action and possible function in health and disease.
    Schor SL; Grey AM; Ellis I; Schor AM; Coles B; Murphy R
    Symp Soc Exp Biol; 1993; 47():235-51. PubMed ID: 8165568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis.
    Schor SL; Grey AM; Picardo M; Schor AM; Howell A; Ellis I; Rushton G
    EXS; 1991; 59():127-46. PubMed ID: 1833226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin fibroblasts obtained from cancer patients display foetal-like migratory behaviour on collagen gels.
    Schor SL; Schor AM; Durning P; Rushton G
    J Cell Sci; 1985 Feb; 73():235-44. PubMed ID: 4019594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of migration stimulating activity in wound fluid.
    Picardo M; Grey AM; McGurk M; Ellis I; Schor SL
    Exp Mol Pathol; 1992 Aug; 57(1):8-21. PubMed ID: 1397194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity (MSFI).
    Jones SJ; Florence MM; Ellis IR; Kankova K; Schor SL; Schor AM
    Exp Cell Res; 2007 Dec; 313(20):4145-57. PubMed ID: 17949711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
    Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration Stimulating Factor (MSF): Its Role in the Tumour Microenvironment.
    Schor AM; Woolston AM; Kankova K; Harada K; Aljorani LE; Perrier S; Felts PA; Keatch RP; Schor SL
    Adv Exp Med Biol; 2021; 1329():351-397. PubMed ID: 34664248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention.
    Schor AM; Schor SL
    Eye (Lond); 2010 Mar; 24(3):450-8. PubMed ID: 20019766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult, foetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during foetal development.
    Schor SL; Schor AM; Rushton G; Smith L
    J Cell Sci; 1985 Feb; 73():221-34. PubMed ID: 4019593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motogenic and biosynthetic response of adult skin fibroblasts to TGF-beta isoforms (-1, -2 and -3) determined by 'tissue response unit': role of cell density and substratum.
    Ellis IR; Banyard J; Schor SL
    Cell Biol Int; 1999; 23(9):593-602. PubMed ID: 10728570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin.
    Schor SL; Ellis I; Dolman C; Banyard J; Humphries MJ; Mosher DF; Grey AM; Mould AP; Sottile J; Schor AM
    J Cell Sci; 1996 Oct; 109 ( Pt 10)():2581-90. PubMed ID: 8923219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing.
    Irwin CR; Picardo M; Ellis I; Sloan P; Grey A; McGurk M; Schor SL
    J Cell Sci; 1994 May; 107 ( Pt 5)():1333-46. PubMed ID: 7929639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous migration of human fetal skin fibroblasts into a denuded area in a cell monolayer is mediated by basic fibroblast growth factor and collagen.
    Kondo H; Matsuda R; Yonezawa Y
    In Vitro Cell Dev Biol Anim; 1993 Dec; 29A(12):929-35. PubMed ID: 8167916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms.
    Ellis IR; Schor SL
    Cytokine; 1998 Apr; 10(4):281-9. PubMed ID: 9617573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.